|
1
|
Yang SY, Zheng Y, Chen JY, Zhang QY, Zhao
D, Han DE and Chen XJ: Comprehensive study of cationic liposomes
composed of DC-Chol and cholesterol with different mole ratios for
gene transfection. Colloids Surf B Biointerfaces. 101:6–13. 2013.
View Article : Google Scholar
|
|
2
|
Masotti A, Mossa G, Cametti C, Ortaggi G,
Bianco A, Grosso ND, Malizia D and Esposito C: Comparison of
different commercially available cationic liposome-DNA lipoplexes:
parameters influencing toxicity and transfection efficiency.
Colloids Surf B Biointerfaces. 68:136–144. 2009. View Article : Google Scholar
|
|
3
|
Templeton NS, Lasic DD, Frederik PM, Strey
HH, Roberts DD and Pavlakis GN: Improved DNA: liposome complexes
for increased systemic delivery and gene expression. Nat
Biotechnol. 15:647–652. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim SY, Lee SJ and Lim SJ: Formulation and
in vitro and in vivo evaluation of a cationic emulsion as a vehicle
for improving adenoviral gene transfer. Int J Pharm. 475:49–59.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roberts R, Al-Jamal WT, Whelband M, Thomas
P, Jefferson M, van den Bossche J, Powell PP, Kostarelos K and
Wileman T: Autophagy and formation of tubulovesicular
autophagosomes provide a barrier against nonviral gene delivery.
Autophagy. 9:667–682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fritze A, Hens F, Kimpfler A, Schubert R
and Peschka-Süss R: Remote loading of doxorubicin into liposomes
driven by a transmembrane phosphate gradient. Biochim Biophys Acta.
1758:1633–1640. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de la Torre LG, Rosada RS, Trombone APF,
Frantz FG, Coelho-Castelo AA, Silva CL and Santana MH: The synergy
between structural stability and DNA-binding controls the antibody
production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes.
Colloids Surf B Biointerfaces. 73:175–184. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen J, Yu Z, Chen H, Gao J and Liang W:
Transfection efficiency and intracellular fate of polycation
liposomes combined with protamine. Biomaterials. 32:1412–1418.
2011. View Article : Google Scholar
|
|
9
|
Pozzi D, Marchini C, Cardarelli F,
Salomone F, Coppola S, Montani M, Zabaleta ME, Digman MA, Gratton
E, Colapicchioni V and Caracciolo G: Mechanistic evaluation of the
transfection barriers involved in lipid-mediated gene delivery:
interplay between nanostructure and composition. Biochim Biophys
Acta. 1838:957–967. 2014. View Article : Google Scholar :
|
|
10
|
Liu R, Gan L, Yang X and Xu H: Chitosan as
a condensing agent induces high gene transfection efficiency and
low cytotoxicity of liposome. J Biosci Bioeng. 111:98–103. 2011.
View Article : Google Scholar
|
|
11
|
Hartono SB, Gu W, Kleitz F, Liu J, He L,
Middelberg AP, Yu C, Lu GQ and Qiao SZ: Poly-L-lysine
functionalized large pore cubic mesostructured silica nanoparticles
as biocompatible carriers for gene delivery. ACS Nano. 6:2104–2117.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reynolds F, Weissleder R and Josephson L:
Protamine as an efficient membrane-translocating peptide. Bioconjug
Chem. 16:1240–1245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanasty R, Dorkin JR, Vegas A and Anderson
D: Delivery materials for siRNA therapeutics. Nat Mater.
12:967–977. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sachdeva M and Mo YY: miR-145-mediated
suppression of cell growth, invasion and metastasis. Am J Transl
Res. 2:170–180. 2010.PubMed/NCBI
|
|
15
|
Zhang H, Pu J, Qi T, Qi M, Yang C, Li S,
Huang K, Zheng L and Tong Q: MicroRNA-145 inhibits the growth,
invasion, metastasis and angiogenesis of neuroblastoma cells
through targeting hypoxia-inducible factor 2 alpha. Oncogene.
33:387–397. 2014. View Article : Google Scholar
|
|
16
|
Adammek M, Greve B, Kässens N, Schneider
C, Brüggemann K, Schüring AN, Starzinski-Powitz A, Kiesel L and
Götte M: MicroRNA miR-145 inhibits proliferation, invasiveness, and
stem cell phenotype of an in vitro endometriosis model by targeting
multiple cytoskeletal elements and pluripotency factors. Fertil
Steril. 99:1346–1355.e5. 2013. View Article : Google Scholar
|
|
17
|
Zhu Z, Xu T, Wang L, Wang X, Zhong S, Xu C
and Shen Z: MicroRNA-145 directly targets the insulin-like growth
factor receptor I in human bladder cancer cells. FEBS Lett.
588:3180–3185. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao J, Fan Y, Li Y and Huang L: Strategies
on the nuclear-targeted delivery of genes. J Drug Target.
21:926–939. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Samadikhah HR, Majidi A, Nikkhah M and
Hosseinkhani S: Preparation, characterization, and efficient
transfection of cationic liposomes and nanomagnetic cationic
liposomes. Int J Nanomedicine. 6:2275–2283. 2011.PubMed/NCBI
|
|
20
|
Morille M, Passirani C, Vonarbourg A,
Clavreul A and Benoit JP: Progress in developing cationic vectors
for non-viral systemic gene therapy against cancer. Biomaterials.
29:3477–3496. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hirsch-Lerner D, Zhang M, Eliyahu H,
Ferrari ME, Wheeler CJ and Barenholz Y: Effect of 'helper lipid' on
lipoplex electrostatics. Biochim Biophys Acta. 1714:71–84. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zuhorn IS, Visser WH, Bakowsky U, Engberts
JBFN and Hoekstra D: Interference of serum with lipoplex-cell
interaction: modulation of intracellular processing. Biochim
Biophys Acta. 1560:25–36. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Li H, Sun J, Gao J, Liu W, Li B,
Guo Y and Chen J: DC-Chol/DOPE cationic liposomes: a comparative
study of the influence factors on plasmid pDNA and siRNA gene
delivery. Int J Pharm. 390:198–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang XP and Cui WH: Comparison of
liposome-polycation-DNA(LPD) and monophosphoryl lipid A(MPL)
adjuvant formulations in BALB/c mice models. Immunol Invest.
41:356–366. 2012. View Article : Google Scholar
|
|
25
|
Ma K, Wang DD, Lin Y, Wang J, Petrenko V
and Mao C: Synergetic targeted delivery of sleeping-beauty
transposon system to mesenchymal stem cells using LPD nanoparticles
modified with a phage-displayed targeting peptide. Adv Funct Mater.
23:1172–1181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jalali SA, Sankian M, Tavakkol-Afshari J
and Jaafari MR: Induction of tumor-specific immunity by
multi-epitope rat HER2/neu-derived peptides encapsulated in LPD
nanoparticles. Nanomedicine. 8:692–701. 2012.
|
|
27
|
Obata Y, Saito S, Takeda N and Takeoka S:
Plasmid DNA-encapsulating liposomes: effect of a spacer between the
cationic head group and hydrophobic moieties of the lipids on gene
expression efficiency. Biochim Biophys Acta. 1788:1148–1158. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi B, Sepp-Lorenzino L, Prisco M, Linsley
P, deAngelis T and Baserga R: Micro RNA 145 targets the insulin
receptor substrate-1 and inhibits the growth of colon cancer cells.
J Biol Chem. 282:32582–32590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suh SO, Chen Y, Zaman MS, Hirata H,
Yamamura S, Shahryari V, Liu J, Tabatabai ZL, Kakar S, Deng G, et
al: MicroRNA-145 is regulated by DNA methylation and p53 gene
mutation in prostate cancer. Carcinogenesis. 32:772–778. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sachdeva M, Zhu S, Wu F, Wu H, Walia V,
Kumar S, Elble R, Watabe K and Mo YY: p53 represses c-Myc through
induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA.
106:3207–3212. 2009. View Article : Google Scholar : PubMed/NCBI
|
